Ipsapirone

Ipsapirone
Clinical data
Routes of; administration	Oral
ATC code	none;
Legal status
Legal status	In general: uncontrolled;
Pharmacokinetic data
Elimination half-life	1.3–2.7 hours[medical citation needed]
Identifiers
	IUPAC name 9,9-dioxo-8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-; 9λ6-thia-8-azabicyclo[4.3.0]nona-1,3,5-trien-7-one;
CAS Number	95847-70-4 ;
PubChem CID	56971;
IUPHAR/BPS	42;
ChemSpider	51365 ;
UNII	6J9B11MN0K;
ChEMBL	ChEMBL8412 ;
CompTox Dashboard (EPA)	DTXSID4045688 ;
Chemical and physical data
Formula	C19H23N5O3S
Molar mass	401.49 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C2c1ccccc1S(=O)(=O)N2CCCCN4CCN(c3ncccn3)CC4;
	InChI InChI=1S/C19H23N5O3S/c25-18-16-6-1-2-7-17(16)28(26,27)24(18)11-4-3-10-22-12-14-23(15-13-22)19-20-8-5-9-21-19/h1-2,5-9H,3-4,10-15H2 ; Key:TZJUVVIWVWFLCD-UHFFFAOYSA-N ;
	(verify)

Ipsapirone is a selective 5-HT_1A receptor partial agonist of the piperazine and azapirone chemical classes.^[1] It has antidepressant and anxiolytic effects.^[1] Ipsapirone was studied in several placebo-controlled trials for depression and continues to be used in research.^[2]

Quick Facts Clinical data, Routes ofadministration ...

See also